Gerresheimer AG (GXI.DE)

69,05 +0,60 (+0,88%) Börsenschluss: 05:35PM CEST

Gerresheimer AG

Klaus-Bungert-Strasse 4
Düsseldorf 40468
Germany
49 211 61 81 00
https://www.gerresheimer.com

Sektor(en): Healthcare
Branche: Medical Instruments & Supplies
Vollzeitmitarbeiter: 10.625

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Dietmar Siemssen	CEO of Plastics & Devices and Advanced Technologies Division & Chairman of the Management Board	1,91M	N/A	1963
Dr. Bernd Metzner Ph.D.	CFO & Member of the Management Board	1,19M	N/A	1970
Dr. Lukas Burkhardt	Member of the Management Board	1,16M	N/A	1979
Ms. Katja Schnitzler	Member of Supervisory Board	106k	N/A	1981
Ms. Carolin Nadilo	Corp. Director of Investor Relations	N/A	N/A	N/A
Mr. Helmut Schweiger	MD & GM of Gerresheimer Horsovsky Tyn Plant	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2021 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Gerresheimer AG, together with its subsidiaries, manufactures and sells packaging products, and drug delivery-devices and solutions worldwide. It operates through Plastics & Devices, Primary Packaging Glass, and Advanced Technologies divisions. The Plastics & Devices division offers drug delivery systems, including inhalers, insulin pen systems, prefillable syringes, and diagnostic systems for the pharma, biotech, diagnostics, and medical technology industries; containers and closures, PET bottles, eye droppers, nasal sprays, nebulizers, applicators, and accessories for solid, liquid, and ophthalmic applications; and bottles and containers for nutritional supplements. The Primary Packaging Glass division offers glass primary packaging for pharma and cosmetics industries, such as infusion, dropper, and syrup bottles; injection vials, ampoules, and cartridges; miniature bottles and glass containers for liquid food, spices, and spirits; and packaging solutions for fragrances, deodorants, skin care, and wellness products, as well as beauty and pharmaceutical products. The Advanced Technologies division develops smart drug delivery systems, such as micro pumps, which are used to self-administer medication for Parkinson's disease or heart failure to pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.

Corporate Governance

Gerresheimer AGs ISS Governance QualityScore, Stand 1. Mai 2022, lautet 4. Die grundlegenden Scores sind Audit: 6, Vorstand: 6, Shareholderrechte: 1, Kompensation: 1.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.